Genetic endophenotypes for insomnia of major depressive disorder and treatment-induced insomnia
Major depressive disorder (MDD) is primarily hinged on the presence of either low mood and/or anhedonia to previously pleasurable events for a minimum of 2 weeks. Other clinical features that characterize MDD include disturbances in sleep, appetite, concentration and thoughts. The combination of any...
Main Authors: | Badamasi, Ibrahim Mohammed, Lye, Munn Sann, Ibrahim, Normala, Stanslas, Johnson |
---|---|
Format: | Article |
Published: |
Springer Wien
2019
|
Similar Items
-
A preliminary nuclear magnetic resonance metabolomics study identifies metabolites that could serve as diagnostic markers of major depressive disorder
by: Mohammed Badamasi, Ibrahim, et al.
Published: (2022) -
Association between polymorphism of genes encoding for 5-HT1A and 5-HT2A receptors and response to selective serotonin reuptake inhibitors in Malaysian patients with major depressive disorder
by: Badamasi, Mohammed Ibrahim, et al.
Published: (2017) -
Serotonergic receptor gene polymorphism and response to selective serotonin reuptake inhibitors in ethnic Malay patients with first episode of major depressive disorder
by: Mohammed Badamasi, Ibrahim, et al.
Published: (2021) -
Effect of insomnia in the major depressive disorder
by: Guohong Xu, et al.
Published: (2022-09-01) -
Predictors of recurrence of major depressive disorder
by: Lye, Munn Sann, et al.
Published: (2020)